Yahoo Canada Web Search

Search results

1. en.wikipedia.org › wiki › ZymergenZymergen - Wikipedia

   en.wikipedia.org › wiki › Zymergen

   • Cached

   Zymergen was an American biotechnology company based in Emeryville, California. The company applies genomics and machine learning to research and design chemical producing genetically modified organisms. It claimed that its manufacturing process was safer and cheaper than traditional manufacturing, but was unable to demonstrate this.

2. www.ginkgobioworks.com › ginkgo-acquires-zymergenGinkgo Acquires Zymergen Ginkgo Bioworks

   www.ginkgobioworks.com › ginkgo-acquires-zymergen

   • Cached

   Oct 19, 2022 · Today, we’re pleased to announce our completed acquisition of Zymergen. This is our largest acquisition to date! It’s expected to significantly enhance our platform by integrating strong automation and software capabilities as well as providing a wealth of experience across diverse biological engineering approaches.

3. Videos

   • 

     3:48

     youtube.com

     Zymergen 101

     Sep 13, 2018

     8.4K Views

   • 

     1:51

     youtube.com

     Zymergen We Make Tomorrow_Traditional Chinese

     Apr 22, 2021

     1.5K Views

   • 

     4:14

     youtube.com

     Zymogen Activation | What Is A Zymogen | Proteolytic Activation | Peptide Cleavage | Proenzymes |

     Jan 3, 2021

     12.3K Views

   View all

4. www.forbes.com › sites › amyfeldmanThe Inside Story Of How SoftBank-Backed Zymergen Imploded ...

   www.forbes.com › sites › amyfeldman

   • Cached

   Oct 13, 2021 · The company behind the ad was Zymergen, a California synthetic biology company that had just gone public with a market capitalization of $3 billion. Its three founders — Josh Hoffman, Zach ...

5. www.fiercebiotech.com › biotech › seven-months-after7 months after biotech pivot, Zymergen is acquired by Ginkgo

   www.fiercebiotech.com › biotech › seven-months-after

   • Cached

   Jul 25, 2022 · Zymergen, a synthetic biology company that shifted to drug discovery in January, has been acquired by Ginkgo Bioworks for $300 million. Ginkgo plans to integrate Zymergen's automation and software into its cell engineering platform and explore strategic alternatives for its drug pipeline.

   • Author: James Waldron

6. Images

   • 
   • 

   View all

7. www.forbes.com › sites › dereksaulGinkgo Buys Embattled Biotech Firm Zymergen For Paltry $300 ...

   www.forbes.com › sites › dereksaul

   • Cached

   Jul 25, 2022 · Ginkgo Bioworks acquired biotechnology firm Zymergen, the synthetic biology companies announced Monday morning, marking the final act in Zymergen’s dramatic and brisk fall from grace.

   • Author: Derek Saul

8. www.linkedin.com › company › zymergenZymergen | LinkedIn

   www.linkedin.com › company › zymergen

   Zymergen | 31,531 followers on LinkedIn. Zymergen is now a part of Ginkgo Bioworks!

9. People also ask

   Did Ginkgo Bioworks buy zymergen?

   • You'll be asked to sign into your Forbes account. Ginkgo Bioworks acquired biotechnology firm Zymergen, the synthetic biology companies announced Monday morning, marking the final act in Zymergen’s dramatic and brisk fall from grace. Signage is displayed at the Ginkgo Bioworks facility in Boston.

   Ginkgo Buys Embattled Biotech Firm Zymergen For Paltry $300 Million

   www.forbes.com/sites/dereksaul/2022/07/25/ginkgo-buys-embattled-biotech-firm-zymergen-for-paltry-300-million/

   See all results for this question

   What happened to zymergen?

   • Zymergen raised $500 million when it went public in April, on top of more than $1 billion in venture funding. By August, its CEO was out and the synthetic biology company wouldn’t say when it might have commercial revenue. Here’s what went wrong.

   The Inside Story Of How SoftBank-Backed Zymergen Imploded Four ... …

   www.forbes.com/sites/amyfeldman/2021/10/13/the-inside-story-of-how-softbank-backed-zymergen-imploded-four-months-after-its-3-billion-ipo/

   See all results for this question

   How much is zymergen worth?

   • Signage is displayed at the Ginkgo Bioworks facility in Boston. The all-stock deal values Zymergen at $300 million market capitalization, a far cry from its roughly $3 billion valuation at its initial public offering last April.

   Ginkgo Buys Embattled Biotech Firm Zymergen For Paltry $300 Million

   www.forbes.com/sites/dereksaul/2022/07/25/ginkgo-buys-embattled-biotech-firm-zymergen-for-paltry-300-million/

   See all results for this question

   What does zymergen do?

   • Zymergen was an American biotechnology company based in Emeryville, California. The company applies genomics and machine learning to research and design chemical producing genetically modified organisms. It claimed that its manufacturing process was safer and cheaper than traditional manufacturing, but was unable to demonstrate this.

   Zymergen - Wikipedia

   en.wikipedia.org/wiki/Zymergen

   See all results for this question

10. www.prnewswire.com › news-releases › ginkgo-bioworksGinkgo Bioworks Completes Acquisition of Zymergen - PR Newswire

    www.prnewswire.com › news-releases › ginkgo-bioworks

    • Cached

    Oct 19, 2022 · BOSTON and EMERYVILLE, Calif., Oct. 19, 2022 /PRNewswire/ -- Today, Ginkgo Bioworks (NYSE: DNA ), the leading horizontal platform for cell programming, and Zymergen (Nasdaq: ZY) announced that...